PE42598A1 - Composiciones farmaceuticas para el tratamiento de la rinitis - Google Patents

Composiciones farmaceuticas para el tratamiento de la rinitis

Info

Publication number
PE42598A1
PE42598A1 PE1997000266A PE00026697A PE42598A1 PE 42598 A1 PE42598 A1 PE 42598A1 PE 1997000266 A PE1997000266 A PE 1997000266A PE 00026697 A PE00026697 A PE 00026697A PE 42598 A1 PE42598 A1 PE 42598A1
Authority
PE
Peru
Prior art keywords
compound
rhinitis
tablet
mixture
weight
Prior art date
Application number
PE1997000266A
Other languages
English (en)
Inventor
De Venne Hernan Van
Jean-Pierre Martin
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24521774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE42598(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PE42598A1 publication Critical patent/PE42598A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CARACTERIZADO PORQUE COMPRENDE UNA MEZCLA DE DOS PRINCIPIOS ACTIVOS: (i) UN COMPUESTO SELECCIONADO DE PSEUDOEFEDRINA, FENILPROPANOLAMINA Y FENILEFRINA, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL DE LAS MISMAS; Y, (ii) UN COMPUESTO DE FORMULA (I), EN DONDE: "Y" ES OH o NH2; "X" Y "X`" SON H, F, Cl, ALCOXI C1-C4 o CF3; m Y n SON 1 o 2; SIENDO UN COMPUESTO (I) PREFERIDO EL RACEMATO DEL ACIDO 2-[2-[4-{(4-CLOROFENIL)FENILMETIL]-1-PIPERACINIL]ETOXI]-ACETICO Y SU SAL DIHIDROCLORURO, DENOMINADO "CETIRIZINA" Y SUS ENANTIOMEROS DEXTRORROTATORIO Y LEVORROTATORIO; EN DONDE LAS PROPORCIONES RESPECTIVAS DEL COMPUESTO (i) Y (ii) EN LA MEZCLA DEBE SER: DE 1% A 30% EN PESO DE (ii) Y DE 60% A 99% EN PESO DE (i). TAMBIEN SE REFIEREN A COMPOSICIONES DE LIBERACION CONTROLADA, QUE COMPRENDEN EN EL NUCLEO DEL COMPRIMIDO AL COMPUESTO (i) Y A UN POLIMERO HIDROFILICO HINCHABLE; Y EN EL RECUBRIMIENTO DEL COMPRIMIDO AL COMPUESTO (ii). ESTAS COMPOSICIONES SON MAS EFICACES QUE LA ADMINISTRACION DE LOS DOS COMPUESTOS TOMADOS POR SEPARADO, PARA ALIVIAR LOS SINTOMAS DE LA RINITIS Y EL CATARRO, TALES COMO RINORREA, OBSTRUCCION NASAL, LAGRIMACION Y SIMILARES
PE1997000266A 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de la rinitis PE42598A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,144 US6469009B1 (en) 1996-04-08 1996-04-08 Pharmaceutical compositions for the treatment of rhinitis

Publications (1)

Publication Number Publication Date
PE42598A1 true PE42598A1 (es) 1998-08-17

Family

ID=24521774

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000266A PE42598A1 (es) 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de la rinitis

Country Status (10)

Country Link
US (2) US6469009B1 (es)
AU (1) AU723364B2 (es)
BR (1) BR9701686A (es)
CO (1) CO4820432A1 (es)
GB (1) GB2311940B (es)
GT (1) GT199700037A (es)
NZ (1) NZ314521A (es)
PA (1) PA8426801A1 (es)
PE (1) PE42598A1 (es)
SV (1) SV1997000026A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6651816B2 (en) 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
IL159287A0 (en) * 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
US7403981B2 (en) * 2002-01-04 2008-07-22 Quicksilver Technology, Inc. Apparatus and method for adaptive multimedia reception and transmission in communication environments
TW200406203A (en) * 2002-03-13 2004-05-01 Array Biopharma Inc N3 alkylated banzimidazole derivatives as MEK inhibitors
US20040132743A1 (en) * 2002-06-21 2004-07-08 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories, Inc. Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (levocetirizine dihydrochloride)
ATE386526T1 (de) 2002-07-02 2008-03-15 Ucb Farchim Sa Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis
JP4303925B2 (ja) * 2002-08-19 2009-07-29 篠田プラズマ株式会社 金属酸化膜の形成方法及びガス放電管の２次電子放出膜形成方法
DE60322577D1 (de) * 2002-12-06 2008-09-11 Ucb Farchim Sa Tablette enthaltend efletirizin und pseudoephedrin
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
SG172685A1 (en) 2006-06-28 2011-07-28 Amgen Inc Glycine transporter-1 inhibitors
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748728C (en) * 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5057427A (en) 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
IL98179A0 (en) * 1990-05-21 1992-06-21 Norwich Eaton Pharma Pharmaceutical compositions containing phenylpropanolamine
AU8505991A (en) 1990-09-11 1992-03-30 Richardson-Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
EP0663828B1 (en) 1992-09-24 1998-09-09 Sepracor, Inc. Treating allergic rhinitis and asthma using (-) Cetirizine
EP0661975B1 (en) 1992-09-24 1999-03-17 Sepracor, Inc. Transdermal treatment of urticaria USING OPTICALLY PURE (+) CETIRIZINE
AU678561B2 (en) 1992-10-09 1997-06-05 Procter & Gamble Company, The Pharmaceutical compositions and methods for treating cold symptoms
EP0695175A1 (en) 1993-04-30 1996-02-07 The Procter & Gamble Company Coated pharmaceutical compositions
CA2170488A1 (en) 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
US20010020023A1 (en) 2001-09-06
US6469009B1 (en) 2002-10-22
GB2311940A (en) 1997-10-15
US6489329B2 (en) 2002-12-03
SV1997000026A (es) 1998-11-10
GT199700037A (es) 1998-09-26
MX9702532A (es) 1998-06-30
AU1774097A (en) 1997-10-16
PA8426801A1 (es) 2000-05-24
NZ314521A (en) 1999-09-29
GB2311940B (en) 2000-07-19
BR9701686A (pt) 1998-11-10
AU723364B2 (en) 2000-08-24
CO4820432A1 (es) 1999-07-28
GB9706842D0 (en) 1997-05-21

Similar Documents

Publication Publication Date Title
PE42598A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis
NO20075353L (no) Forbindelser, isomerer og farmasoytisk akseptable salter derav, som vanilloidreseptorantagonister, og farmasoytiske preparater inneholdende slike
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
NO20055977L (no) Nye benzimidazolderivater
BRPI0412219B8 (pt) compostos ômega-carboxi aril difenil uréia fluoro substituídos e composições farmacêuticas compreendendo os referidos compostos
SE0202462D0 (sv) Novel use
US20100158818A1 (en) Antimicrobial n-chlorinated compositions
AR058180A1 (es) Indeno derivados, su preparacion y su uso como medicamentos
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
AR002744A1 (es) Guanidinas de acido alquenilcarboxilico, sustituidas con fluorofenilo, procedimiento para su preparacion, su utilizacion como medicamento o agente dediagnostico, asi como medicamento que las contiene.
WO2009096701A3 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
ECSP21037191A (es) Pirazoles como moduladores de la hemoglobina
AU2011232341B2 (en) Improved stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
AR029461A1 (es) Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento
NO20074617L (no) Nye forbindelser for behandling av inflamotoriske sykdommer
DK0527081T3 (da) Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
AR048716A1 (es) Derivados de acido pentenoico, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden y sus aplicaciones terapeuticas
AR029229A1 (es) Compuestos de piperazina sustituida, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento
SE0201837D0 (sv) Chemical compounds
NO991164L (no) Farmas°ytisk preparat for behandling av virussykdommer
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed